Cargando…
P1695: REAL-WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG U.S. ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-GEMOX IN THE RELAPSED/REFRACTORY SETTING
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429930/ http://dx.doi.org/10.1097/01.HS9.0000973652.79125.42 |
| _version_ | 1785090834049269760 |
|---|---|
| author | Garg, Mahek Puckett, Justin Kamal-Bahl, Sachin Raut, Monika Ryland, Katherine Chakraborty, Samhita Doshi, Jalpa Huntington, Scott |
| author_facet | Garg, Mahek Puckett, Justin Kamal-Bahl, Sachin Raut, Monika Ryland, Katherine Chakraborty, Samhita Doshi, Jalpa Huntington, Scott |
| author_sort | Garg, Mahek |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429930 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104299302023-08-17 P1695: REAL-WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG U.S. ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-GEMOX IN THE RELAPSED/REFRACTORY SETTING Garg, Mahek Puckett, Justin Kamal-Bahl, Sachin Raut, Monika Ryland, Katherine Chakraborty, Samhita Doshi, Jalpa Huntington, Scott Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429930/ http://dx.doi.org/10.1097/01.HS9.0000973652.79125.42 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Garg, Mahek Puckett, Justin Kamal-Bahl, Sachin Raut, Monika Ryland, Katherine Chakraborty, Samhita Doshi, Jalpa Huntington, Scott P1695: REAL-WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG U.S. ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-GEMOX IN THE RELAPSED/REFRACTORY SETTING |
| title | P1695: REAL-WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG U.S. ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-GEMOX IN THE RELAPSED/REFRACTORY SETTING |
| title_full | P1695: REAL-WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG U.S. ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-GEMOX IN THE RELAPSED/REFRACTORY SETTING |
| title_fullStr | P1695: REAL-WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG U.S. ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-GEMOX IN THE RELAPSED/REFRACTORY SETTING |
| title_full_unstemmed | P1695: REAL-WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG U.S. ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-GEMOX IN THE RELAPSED/REFRACTORY SETTING |
| title_short | P1695: REAL-WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG U.S. ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-GEMOX IN THE RELAPSED/REFRACTORY SETTING |
| title_sort | p1695: real-world survival, healthcare resource utilization, and costs among u.s. elderly patients with diffuse large b-cell lymphoma (dlbcl) treated with r-gemox in the relapsed/refractory setting |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429930/ http://dx.doi.org/10.1097/01.HS9.0000973652.79125.42 |
| work_keys_str_mv | AT gargmahek p1695realworldsurvivalhealthcareresourceutilizationandcostsamonguselderlypatientswithdiffuselargebcelllymphomadlbcltreatedwithrgemoxintherelapsedrefractorysetting AT puckettjustin p1695realworldsurvivalhealthcareresourceutilizationandcostsamonguselderlypatientswithdiffuselargebcelllymphomadlbcltreatedwithrgemoxintherelapsedrefractorysetting AT kamalbahlsachin p1695realworldsurvivalhealthcareresourceutilizationandcostsamonguselderlypatientswithdiffuselargebcelllymphomadlbcltreatedwithrgemoxintherelapsedrefractorysetting AT rautmonika p1695realworldsurvivalhealthcareresourceutilizationandcostsamonguselderlypatientswithdiffuselargebcelllymphomadlbcltreatedwithrgemoxintherelapsedrefractorysetting AT rylandkatherine p1695realworldsurvivalhealthcareresourceutilizationandcostsamonguselderlypatientswithdiffuselargebcelllymphomadlbcltreatedwithrgemoxintherelapsedrefractorysetting AT chakrabortysamhita p1695realworldsurvivalhealthcareresourceutilizationandcostsamonguselderlypatientswithdiffuselargebcelllymphomadlbcltreatedwithrgemoxintherelapsedrefractorysetting AT doshijalpa p1695realworldsurvivalhealthcareresourceutilizationandcostsamonguselderlypatientswithdiffuselargebcelllymphomadlbcltreatedwithrgemoxintherelapsedrefractorysetting AT huntingtonscott p1695realworldsurvivalhealthcareresourceutilizationandcostsamonguselderlypatientswithdiffuselargebcelllymphomadlbcltreatedwithrgemoxintherelapsedrefractorysetting |